{"issuance_frequency":"","notes_translated":{"fr":"L'entreprise pharmaceutique doit remplir un des formulaires ci-dessous et le présenter au commissaire aux brevets. L'entreprise devrait choisir le formulaire qui correspond à l'annexe sur laquelle le pays importateur figure ainsi que l'état du brevet du produit pharmaceutique en question dans ce pays importateur. ","en":"The pharmaceutical company must complete and submit to the Commissioner of Patents one of the forms listed below. The company should choose the form that corresponds to the schedule on which the importing country appears, as well as the patent status of the pharmaceutical product in that country."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"f0d692f2-1aae-4499-a59e-201597a18efc","metadata_created":"2020-09-17T19:30:41.739971","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2020-09-17T19:30:41.739994","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-09-17","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Régime canadien d'accès aux médicaments","déclaration de l'identité et de l'état du brevet du produit pharmaceutique","entreprise pharmaceutique","commissaire aux brevets"],"en":["Canada's Access to Medicines Regime","declare identity and patent status of pharmaceutical product","pharmaceutical company","Commissioner of Patents."]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Déclaration de l'identité et de l'état du brevet du produit pharmaceutique : Régime canadien d'accès aux médicaments","en":"Declare identity and patent status of pharmaceutical product under Canada's Access to Medicines Regime"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"f0d692f2-1aae-4499-a59e-201597a18efc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4ca1b1a4-9574-49ae-8d2d-92d2b75cca00","related_relationship":"","name_translated":{"fr":"Déclaration de l'identité et de l'état du brevet du produit pharmaceutique : Régime canadien d'accès aux médicaments","en":"Declare identity and patent status of pharmaceutical product under Canada's Access to Medicines Regime"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Declare identity and patent status of pharmaceutical product under Canada's Access to Medicines Regime","language":["en"],"created":"2020-09-17T19:30:41.825365","url":"https://www.canada.ca/en/health-canada/services/canada-access-medicines-regime/companies/forms/declare-identity-patent-status-pharmaceutical-product.html","last_modified":null,"position":0,"revision_id":"5bb22ea3-8720-485f-b731-a290b5ea72ad","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"f0d692f2-1aae-4499-a59e-201597a18efc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"5b06d212-2fd4-422c-b237-9d62b58a98d8","related_relationship":"","name_translated":{"fr":"Déclaration de l'identité et de l'état du brevet du produit pharmaceutique : Régime canadien d'accès aux médicaments","en":"Declare identity and patent status of pharmaceutical product under Canada's Access to Medicines Regime"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Declare identity and patent status of pharmaceutical product under Canada's Access to Medicines Regime","language":["fr"],"created":"2020-09-17T19:30:41.825372","url":"https://www.canada.ca/fr/sante-canada/services/regime-canadien-acces-medicaments/entreprises/formulaires/declaration-identite-etat-brevet-produit-pharmaceutique.html","last_modified":null,"position":1,"revision_id":"5bb22ea3-8720-485f-b731-a290b5ea72ad","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2017-04-28 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"f0d692f2-1aae-4499-a59e-201597a18efc","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The pharmaceutical company must complete and submit to the Commissioner of Patents one of the forms listed below. The company should choose the form that corresponds to the schedule on which the importing country appears, as well as the patent status of the pharmaceutical product in that country.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Declare identity and patent status of pharmaceutical product under Canada's Access to Medicines Regime","revision_id":"5bb22ea3-8720-485f-b731-a290b5ea72ad"}